Elevated levels of miR-21 in cardiofibroblasts activate the MAPK signaling pathway by inhibiting the sprouty homolog 1 (SPRY1) protein, which promotes cardiac remodeling and cardiac hypertrophy [176,177]. This evidence concerns the gene SPRY1 and cardiac hypertrophy.